FcγRIIB Is an Immune Checkpoint Limiting the Activity of Treg-Targeting Antibodies in the Tumor MicroenvironmentDavid A. Knorr, Jeffrey V. Ravetch, Lucas Blanchard et al.|Cancer Immunology Research|2023Cited by 32
FcyRIIB is a novel immune checkpoint in the tumor microenvironment limiting activity of Treg-targeting antibodiesDavid A. Knorr, Jeffrey V. Ravetch, Rom S. Leidner et al.|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 2
Supplementary Figure 3 from FcγRIIB Is an Immune Checkpoint Limiting the Activity of Treg-Targeting Antibodies in the Tumor MicroenvironmentDavid A. Knorr, Jeffrey V. Ravetch, Lucas Blanchard et al.|Unknown|2024Cited by 0
Supplementary Figure 4 from FcγRIIB Is an Immune Checkpoint Limiting the Activity of Treg-Targeting Antibodies in the Tumor MicroenvironmentDavid A. Knorr, Jeffrey V. Ravetch, Lucas Blanchard et al.|Unknown|2024Cited by 0
Supplementary Figure 4 from FcγRIIB Is an Immune Checkpoint Limiting the Activity of Treg-Targeting Antibodies in the Tumor MicroenvironmentDavid A. Knorr, Jeffrey V. Ravetch, Lucas Blanchard et al.|Unknown|2024Cited by 0